Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Dec 2022 |
|---|---|---|---|---|
| Total reported revenue | — | 23.9B | 23.7B | 23.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | — | 3.2B | 3.3B | 3.1B |
| Tax provision | — | — | — | — |
| Net income | — | 2.4B | 2.5B | 2.4B |
| Basic EPS | 0.2 | — | — | — |
| Diluted EPS | 0.2 | — | — | — |
| Basic average shares | 17.6B | — | — | — |
| Diluted average shares | 17.6B | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | 0 | 0 | 0 |